We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differentia... Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. Show more
CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024...
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is...
CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and...
In Monday’s pre-market trading, U.S. index futures are mixed, with Wall Street in anticipation of the monetary policy guidelines that the Federal Reserve is expected to release during the...
CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital...
CARLSBAD, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter and year ended December...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.709219858156 | 1.41 | 1.42 | 1.3188 | 12357 | 1.38107694 | CS |
4 | -0.12 | -7.89473684211 | 1.52 | 1.5431 | 1.3003 | 15543 | 1.43834576 | CS |
12 | -0.58 | -29.2929292929 | 1.98 | 2.29 | 1.3003 | 33407 | 1.68161757 | CS |
26 | -0.34 | -19.5402298851 | 1.74 | 2.4 | 1.3003 | 46448 | 1.80535996 | CS |
52 | -1.22 | -46.5648854962 | 2.62 | 3.9232 | 1.3003 | 30779 | 2.01922168 | CS |
156 | -15.44 | -91.6864608076 | 16.84 | 17.9814 | 1.3003 | 43366 | 6.60240364 | CS |
260 | -15.4 | -91.6666666667 | 16.8 | 29.858 | 1.3003 | 46142 | 10.79769208 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions